20th International Congress » Other

Date: Thursday, June 23, 2016

Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:00pm-1:30pm: “Words untold”

P.M. Iyer, B. McGuiness, J. Scott, S. Manning, A. Chalisseri, D. Olszewska, M. Farrell, T. Lynch (Dublin, Ireland)

12:00pm-1:30pm: A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery

E.M. Feinstein, S.J. Frucht (New York, NY, USA)

12:00pm-1:30pm: A case with posttraumatic functional shoulder dyskinesia

S. Tezcan, M. Demirci, M.C. Akbostanci (Ankara, Turkey)

12:00pm-1:30pm: A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines

G.M. Solinap, A.C. Aguil, P.B. Acuna, L.V. Lee, N. Sharma (Charlestown, MA, USA)

12:00pm-1:30pm: A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines

S.M. Yap, M.O. Dablouk, S. O'Sullivan (Dublin, Ireland)

12:00pm-1:30pm: A cross-linguistic approach to speech intelligibility in people with PD

Y. Kim, Y. Choi (Baton Rouge, LA, USA)

12:00pm-1:30pm: A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

12:00pm-1:30pm: A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test

E. Goz, F. Soke, A. Genc, B. Donmez Colakoglu, P. Keskinoglu (Izmir, Turkey)

12:00pm-1:30pm: A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

12:00pm-1:30pm: Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

12:00pm-1:30pm: Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm: Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases

F. Pullishery, F.M. Kuyyadi (Malappuram, India)

12:00pm-1:30pm: Association of amyotrophic lateral sclerosis with basal ganglia impairment

D. Mirzaeva, A. Prokhorova, B. Muinjanov, P. Deleyn (Tashkent, Uzbekistan)

12:00pm-1:30pm: Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa

J. Mokaya, J. Carr (Tygerberg, South Africa)

12:00pm-1:30pm: Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients

A. Romagnolo, M.G. Rizzone, F. Dematteis, M. Zibetti, A. Merola, L. Rizzi, E. Montanaro, C.A. Artusi, M. Lanotte, L. Lopiano (Turin, Italy)

12:00pm-1:30pm: Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

12:00pm-1:30pm: Characterization of European longitudinal cohort studies in Parkinson’s disease – Report of the JPND working group BioLoC-PD

S. Lerche, I. Liepelt-Scarfone, G. Alves, P. Barone, S. Behnke, Y. Ben-Shlomo, H. Berendse, D. Burn, R. Dodel, D. Grosset, M. Hu, M. Kasten, R. Krüger, W. Maetzler, B. Mollenhauer, W. Oertel, U. Walter, K. Wirdefeldt, D. Berg (Tübingen, Germany)

12:00pm-1:30pm: Colonic α-synuclein: A potential diagnostic biomarker in Parkinson’s disease

C. Ruffmann, I. Poggiolini, N. Bengoa-Vergniory, F. Baig, M. Rolinski, J. Klein, M.T. Hu, R. Wade-Martins, J. Alegre-Abarrategui, L. Parkkinen (Oxford, United Kingdom)

12:00pm-1:30pm: Comparing quality of PD care in a comprehensive clinic to specialist care

S.A. Factor, L.P. Prizer, F.C. Goldstein, L.M. Trotti, A. Hermida, C. Vaughan (Atlanta, GA, USA)

12:00pm-1:30pm: Conjugal Parkinson´s disease – Real or chance?

B. Balint, R. Erro, F. Brugger, A. Batla, E. Antelmi, C. Ganos, K.P. Bhatia (London, United Kingdom)

12:00pm-1:30pm: Coupling between visual information and body sway in people with Parkinson’s disease

C.F. Cruz, L.A.O.A. Nóbrega, E. Okamoto, M.E.P. Piemonte, J.A. Barela (São Paulo, Brazil)

12:00pm-1:30pm: Creutzfeldt-Jakob disease presenting predominantly with movement disorder: A case report

A.A. Sann, M.M. Zaw, T.L. Choie (Yangon, Myanmar)

12:00pm-1:30pm: CSF level of chromogranin A in amyotrophic lateral sclerosis

M. Kaiserova, P. Otruba, K. Mensikova, Z. Grambalova, H. Prikrylova Vranova, J. Mares, D. Stejskal, P. Kanovsky (Olomouc, Czech Republic)

12:00pm-1:30pm: Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke

F. Fluri, M.K. Schuhmann, C. Kleinschnitz, J. Volkmann (Würzburg, Germany)

12:00pm-1:30pm: Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

P.C. Bhatt, V. Kumar (New Delhi, India)

12:00pm-1:30pm: Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

12:00pm-1:30pm: Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

S.H. Guptha (Peterborough, United Kingdom)

12:00pm-1:30pm: ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis

S. Mariani, P. Congiu, G. Milioli, G. Gioi, G. Borghero, F. Marrosu, R.J. Thomas, A.L. Goldberger, M. Puligheddu (Boston, MA, USA)

12:00pm-1:30pm: EEG Spectral power changes prior to non-epileptic seizures: A pilot study

A.M. Meppelink, I. Parees, M. Beudel, S. Little, M. Edwards (Groningen, Netherlands)

12:00pm-1:30pm: Effect of dopamine and L-3,4 – dihydroxyphenylalanine in treatment of experimental parkinsonism

M.U. Kulmanova (Tashkent, Uzbekistan)

12:00pm-1:30pm: Effect of nelotanserin on objective sleep parameters in a phase 2 study in patients with insomnia

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, M. Sanchez, W. Shanahan (New York, NY, USA)

12:00pm-1:30pm: Effectiveness of Lee Silverman voice treatment big on improving gait and quality of life in Parkinson’s disease patients after STN-DBS

V.V.P. Kagita, N.N. Mohd, A.K. Puligopu, R.M. Kandadai, M.A. Kanikannan, S. Jabeen, R. Borgohain (Hyderabad, India)

12:00pm-1:30pm: Effects of movement rate and amplitude on repetitive finger motion in people with Parkinson’s disease and freezing of gait

M.P. Pereira, S. Vercruysse, E. Heremans, A. Nieuwboer (Leuven, Belgium)

12:00pm-1:30pm: European physiotherapy guideline for Parkinson’s disease: Information for neurologists

D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

12:00pm-1:30pm: Evaluation of respiratory and depression levels of patients with Parkinson’s disease

E.E. Okuyucu, O. Canbay, E. Dogru, I. Huzmeli, N. Katayifci, F. Duman, N.C. Korkmaz, B. Yucekaya, E. Seker (Hatay, Turkey)

12:00pm-1:30pm: Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia

W. Wen, K. Kishnani, S. Ramaswamy, S. Piscitelli (New York, NY, USA)

12:00pm-1:30pm: Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up

M.T. Montojo, Y. Macias, M. ÁLvarez, C. Martín, L. Borrega, L. Vela (Alcorcón, Spain)

12:00pm-1:30pm: Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies

M. Takahashi, T. Uchihara, M. Yoshida, K. Wakabayashi, A. Kakita, H. Takahashi, S. Toru, T. Kobayashi, S. Orimo (Tokyo, Japan)

12:00pm-1:30pm: Fall status and stepping response: Individuals with PD are differently influenced by side-affected

B.N. Intzandt, E. Beck, M.P. Pereira, Q.J. Almeida (Waterloo, ON, Canada)

12:00pm-1:30pm: Finding an optimal lead trajectory for a better stimulated volume in movement disorder therapy

J. Perez, L. Cif, V. Gonzalez, E. Sanrey, F. Cyprien, P. Coubes (Montpellier, France)

12:00pm-1:30pm: Frequency of falls in nursing homes for neurodegenerative diseases

C. Godinho, J.M. Domingos, A.S. Pereira, M. Duarte, J.J. Ferreira (Lisboa, Portugal)

12:00pm-1:30pm: Gait and anthropometric characteristics of patients with Parkinson’s disease seen in a Nigerian tertiary hospital

A.O. Ogundele, M.O. Olaogun, M.A. Komolafe (Ile-Ife, Nigeria)

12:00pm-1:30pm: Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)

12:00pm-1:30pm: Glial cells and iron accumulation in the brain of the Zitter rat

T. Kadowaki, H. Lassmann, S. Ueda, C. Schuh, K. Hirata (Mibu, Japan)

12:00pm-1:30pm: Has iCare PD started in Singapore?

S.H.X. Liew, C. Cyq, N. Jcf, K. Sym, R.C.L. Ong (Singapore, Singapore)

12:00pm-1:30pm: Home care program for patients with Parkinson’s disease – A Singapore experience

H.L. Ng, W. Li, S. Abdul Karim, K.Y. Tay, W.L. Au, L.C.S. Tan (Singapore, Singapore)

12:00pm-1:30pm: How accurate is the prediction of driving ability in a Parkinson’s clinic setting?

C. Thomas, R. Amin, B. Mohamed (Cardiff, United Kingdom)

12:00pm-1:30pm: Improving the experience of diagnosis in Parkinson’s disease

C. Carroll, B. Blight, V. Evans, N. Hawkes, J. Davis (Plymouth, United Kingdom)

12:00pm-1:30pm: Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study

S. Aithal, C. Thomas, S. Raha, H. Shukla, L. Ebenezer, R. Sequeria, B. Mohamed (Caerphilly, United Kingdom)

12:00pm-1:30pm: Interdisciplinary allied health care in a southern Brazil service

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm: Is physiotherapy an effective for treatment of Parkinson’s disease?!

R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)

12:00pm-1:30pm: Long-latency somatosensory evoked potentials of the subthalamic nucleus

C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

12:00pm-1:30pm: Loss of heart rate variability in ALS: Time and frequency domain assessment

P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

12:00pm-1:30pm: Nursing diagnoses and interventions in rehabilitation related to antiParkinsonian pharmacotherapy

M.H.S. Tosin, B.G.R.B. Oliveira, T.R. Garcia (Rio de Janeiro, Brazil)

12:00pm-1:30pm: Ocular flutter in alcohol withdrawal syndrome

K.P. Frei, M. Dastjerdi, F.B. Pedouim, L.H. Sovory, K. Dashtipour (Loma Linda, CA, USA)

12:00pm-1:30pm: Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy

L.E. Katus, S.J. Frucht (New York, NY, USA)

12:00pm-1:30pm: Parkinson’s disease (PD) quality improvement measures (QIM) and outcomes study

J. Martello, L. Shulman, M. Armstrong, S. Reich (Baltimore, MD, USA)

12:00pm-1:30pm: Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA

B. Elibol, H. Onder, G.Y. Cakmakli, E.S. Topcuoglu (Ankara, Turkey)

12:00pm-1:30pm: Participant feedback in the PREDICT-PD study

C.W. Osborne, J. Bestwick, G. Giovannoni, A.J. Lees, A. Schrag, A. Noyce (London, United Kingdom)

12:00pm-1:30pm: Physical therapy, a third wheel in the management of Parkinson’s disease

M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)

12:00pm-1:30pm: Physiological and biomechanical responses of people with Parkinson’s during Zumba Gold®: Effects of dance styles and number of sessions

A. Delextrat, J. Bateman, P. Esser, N. Targen, H. Dawes, M.A. Delextrat (Oxford, United Kingdom)

12:00pm-1:30pm: Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution

E.T.N. Guelfi, E. Okamoto, F.B. Tarallo, J.C. Elmauer, R.R. Fermino, V.F. Giangiardi, P. Yuki, E.P. Piemonte (São Paulo, Brazil)

12:00pm-1:30pm: Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm: Predictive validity of statistical models of Parkinson’s disease progression

A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)

12:00pm-1:30pm: Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)

12:00pm-1:30pm: Profile of urgent care visits in movement disorders

J.T. Lazarus, V.D. Sharma, L. Scorr, S. Factor (Atlanta, GA, USA)

12:00pm-1:30pm: Progressive encephalomyelitis with rigidity and myoclonus (PERM) in an intellectually disabled patient initially misdiagnosed as neuroleptic malignant syndrome (NMS)

Z. Xu, K. Prasad, T. Yeo (Singapore, Singapore)

12:00pm-1:30pm: Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates

B.D. Wissel, A.K. Dwivedi, T.E. Gaston, F.J. Rodriguez-Porcel, D. Al Jaafari, J.L. Hopp, A. Krumholz, Y. Wang, S.M.A. van der Salm, D.M. Andrade, F. Borlot, B.D. Moseley, J.L. Cavitt, S. Williams, J. Stone, W.C. LaFrance Jr, J.P. Szaflarski, A.J. Espay (Cincinnati, OH, USA)

12:00pm-1:30pm: Relationship between balance, trunk impairment and hand function in Parkinson’s disease

B. Donmez Colakoglu, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

12:00pm-1:30pm: Relationship of muscular strength with cardiovascular function in Parkinson’s disease

M.A. Alomari, H. Khalil, O.F. Khabour, E. Dersieh, J.A. Bajwa (Irbid, Jordan)

12:00pm-1:30pm: Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease

T.E. Apoznanski, S. Yao, M.K. Jung, J. DiFrancisco-Donoghue (Old Westbury, NY, USA)

12:00pm-1:30pm: Risk factors associated with postural changes in Parkinson’s disease

A. Khlebtovsky, O. Keret, Y. Rodity, G. Tsvetov, I. Slutzcki-Shraga, F. Benninger, R. Djaldetti (Petach Tikva, Israel)

12:00pm-1:30pm: Role of the nurse coordinator within a unit for treatment of neuro-surgical behaviours and abnormal movements

E. Borgeais, C. Fournera, I. Creff, P. Coubes (Montpellier, France)

12:00pm-1:30pm: Safety of nelotanserin in a randomized placebo-controlled phase 2 study

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)

12:00pm-1:30pm: Sarcopenia and dynapenia in patients with parkinsonism

E. Cassani, E. Cereda, G. Pinelli, L. Iorio, A. Valentino, C. Pusani, V. Ferri, C. Bolliri, M. Pasqua, G. Frazzitta, M. Barichella, G. Pezzoli (Milano, Italy)

12:00pm-1:30pm: Self-perception of vocal handicap in Parkinson’s disease

A.K. Silbergleit, J. Wall, L. Schultz, J. Peacock, P.A. LeWitt (West Bloomfield, MI, USA)

12:00pm-1:30pm: Stiff person syndrome

P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))

12:00pm-1:30pm: Stiff person syndrome: Case series

E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)

12:00pm-1:30pm: STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)

12:00pm-1:30pm: Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)

12:00pm-1:30pm: Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse

K.F. Heil, O. Sorokina, J.D. Armstrong, J. Hellgren Kotaleski (Edinburgh, United Kingdom)

12:00pm-1:30pm: Testing for the “whack-a-mole” sign in the movement disorders clinic

J.E. Park, C. Maurer, M. Villegas, M. Hallett (Bethesda, MD, USA)

12:00pm-1:30pm: The communicative effectiveness survey-revised (CESR): An objective measure of communicative participation for people with Parkinson’s disease

N.J. Donovan (Baton Rouge, LA, USA)

12:00pm-1:30pm: The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2

F.S. Akhmedova, M.K.U. Tukhtamishev (Tashkent, Uzbekistan)

12:00pm-1:30pm: The effect of daytime working for development of sleep apnea in office workers

D.M. Sultonov, U.N. Vokhidov (Tashkent, Uzbekistan)

12:00pm-1:30pm: The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

12:00pm-1:30pm: The role of acoustic salience in acoustic cueing and sound-based motor rehabilitation

B.G. Schultz, S.A. Kotz (Maastricht, Netherlands)

12:00pm-1:30pm: The role of active rehabilitation measures, for maintaining the quality of life of patients after stroke with movement disorders in the general practice conditions

G. Sadullaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm: The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

12:00pm-1:30pm: The serum response factor SRF protect dopamine (DA) neurons in Parkinson’s disease partially by mediate autophagy through a beclin 1-dependent pathway

X. Cheng (Suzhou, People's Republic of China)

12:00pm-1:30pm: Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)

12:00pm-1:30pm: TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells

X. Cheng, M. Wang (Suzhou, People's Republic of China)

« View all sessions from the 20th International Congress.